Hearing triple-negative breast cancer (TNBC) can feel overwhelming. At Learn Look Locate, we created a patient-first resource that blends trusted medical guidance with lived experience—so you don’t have to navigate TNBC alone.
This page is led by Maryam Lustberg, MD, MPH—Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, Chief of Breast Medical Oncology, and Professor of Internal Medicine (Medical Oncology) at Yale School of Medicine. Her leadership ensures every section is accurate, compassionate, and truly patient-centered.
TNBC doesn’t have estrogen or progesterone receptors and isn’t HER2-positive, which changes treatment paths and makes early detection vital.
Real experiences appear throughout your TNBC guide to help you feel seen and supported:
Care often includes chemotherapy, immunotherapy in eligible settings, targeted approaches for BRCA-mutation carriers, and more – plus the option to explore clinical trials. For a simple, calm place to search every current breast cancer clinical trial, visit our Clinical Trials resource (powered through our BreastCancerTrials.org collaboration).
Our page explains TNBC’s unique behavior, who is more often affected, and why proactive screening and self-awareness are so important – presented in plain language with supportive context.
This is one of the most patient-centered pages on Learn Look Locate – guided by Dr. Lustberg and interwoven with survivor perspectives to offer a soft landing place as you learn, ask, and prepare. Explore the full TNBC guide on our site
Share This Story, Choose Your Platform!